exam 2 study guide Flashcards

1
Q
  1. What is the cause of trinucleotide repeat diseases?
A

expansions of pre-existing unstable tandem repeat sequences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The expansions of unstable repeats are caused by what reason and occur within which regions of the genes?

A

caused by the slippage of DNA polymerase during DNA replication or repair

-This is within the CAG DNA sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are the three pathogenic mechanisms underlying trinucleotide repeat diseases?

A
  1. loss of function of protein
  2. gain of function of RNA
  3. gain of function of protein (expansion of CAG-repeat)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the important features of trinucleotide repeat disease

A

-inherited
-intergenerational repeat instability
-anticipation
-variability in expressivity or severity of the disease
-selective vulnerability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the offspring with the further-expanded repeat have an earlier onset and more severe disease course than did the parent

A

anticipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

repeat length rarely causing a disease but that is likely to expand to disease-causing mutation length in successive generations

A

premutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mutation in which gene causes Fragile X Syndrome?

A

FMR1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what happens when there is the protein (frataxin) function

A

causes iron accumulation in the mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the pathogenic mechanism of Friedreich Ataxia?

A

loss of protein (frataxin) function -> iron accumulation in the mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the pathogenic mechanism of spinobulbar muscular atrophy?

A

caused by expansion of a CAG repeat in the coding region of the androgen receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

why does spinobulbar muscular atrophy mainly affect males

A

females usually do not have enough androgens to bring mutated androgen receptors to the nucleus to mediate their pathogenic effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the pathogenic mechanism of mutant Ataxin-1 in Spinocerebellar Ataxias 1?

A

Gain of protein function in Ataxin 1 causes SCA1

Mutant Ataxin‐1 then contributes to SCA1 pathogenesis through disturbing the transcriptional corepressors/ coactivators pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
  1. Huntingtin is a _____ ______protein to mediate protein-protein interaction and is involved in many pathway
A

multifunctional scaffold

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Mutant Huntingtin alters the protein interacting with different proteins, thereby disrupting many _____ functions

A

cellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Fragile X Syndrome loss of protein function, gain of RNA function, gain of protein function?

A

loss of protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myotonic Dystrophy I & II loss of protein function, gain of RNA function, gain of protein function?

A

gain of RNA function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Fragile X–Associated Tremor Ataxia

A

Gain of function of toxic RNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Friedreich Ataxia

A

Loss of protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Spinobulbar Muscular Atrophy (polyQ disease)

A

Gain of function of toxic protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Spinocerebellar Ataxia 1 (polyQ) disease)

A

gain of function of toxic protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Huntington’s Disease (polyQ disease)

A

Gain of function of toxic protein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

TDP43 (ALS) gain of function, loss of function, or both?

A

both

gain of function (cytoplasmic aggregation) and loss of function (abnormal RNA processing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

1.loss of protein (DPR) function;
(2) gain of function of the toxic RNA;
(3) gain of function of toxic protein (DPR protein accumulation)

A

C9ORF72

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

SOD1 (ALS) mechanism

A

gain of toxic function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q
  1. ALS patients not only have motor symptoms but usually FTLD symptoms too during disease progression.
  2. FTLD patients also have ALS symptoms.
  3. ALS and FTLD have the same pathological protein inclusions: TDP 43 & FUS
  4. Inherited ALS and FTLD patients have the same genetic cause: chromosome 9 open reading frame 72 mutation
A

Why amyotrophic lateral sclerosis and frontotemporal lobe degeneration viewed as the same disease?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

types of neurons affected in ALS

A

UMNs, LMNs, Frontal cortex neurons, temporal neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Which type of neurons are least vulnerable in ALS

A

Sensory, autonomic and cerebellar neurons are mostly spared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What are the three different histopathological inclusions in ALS?

A

Bunina bodies
skein-like inclusions (TDP-43)
basophilic inclusion (FUS inclusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

-protein aggregation
-alterations in RNA metabolism
-oxidative stress
-mitochondria dysfunction
-impaired axonal transport
–impaired protein degradation

**Glial cells are also involved

A

pathological mechanism is ALS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

SOD1 is involved in _____ ____ ____(prevents oxidative damage)

A

free radical scavenging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

-Mutant SOD1 misfolds and has toxic effects on the cell’s protein degradation machinery, impairing both the ubiquitin-proteasome and autophagy pathway

Wild‐type SOD1 is aggregation‐prone: in sporadic ALS, oxidized wild type SOD can misfold and is toxic to motor neurons t/f

A

t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

How do UBQLN2 and Valosin-containing proteins (VCP) get involved in ALS pathogenesis?

A

contains proteins that impair protein degradation machinery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

What are the pathogenic mechanisms caused by repeat expansion in the C9ORF72 gene in ALS?

loss of protein mRNA levels get reduced by 50% (may be _____ causing loss of function effect)

A

haploinsufficency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the pathogenic mechanisms caused by repeat expansion in the C9ORF72 gene in ALS?

A

gain of toxic RNA function

loss of protein function –> haploinsuffuciency

gain of protein function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q
  • The common:
  • Both TDP43 and FUS are RNA-binding proteins
  • Both TDP43 and FUS bind to very long intron sequences
  • Both TDP43 and FUS have the prion-like domain renders the aggregation propensity
  • Both TDP43 and FUS shuttle between nucleus and cytoplasm
A

common btw TDP-43 FUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

t/f - TDP43 and FUS co-aggregates in the same protein inclusion

A

false, it doesn’t

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the two clinical disease course of most MS?

A

RRMS and SPMS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

caused by focal areas of inflammatory demyelination followed by resolution of the inflammation and edema and remyelination

A

Relapsing-remitting MS (RRMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

after one to two decades, RRMS patients enter a second disease phase characterized by a continuous irreversible neurological disability

A

Secondary progressive state of MS (SPMS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

what is the major MS-associated gene that influences MS disease susceptibility?

A

HLADRB1 gene (The only consistent MS‐associated gene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the major reason for irreversible neurological functional decline in MS patients in the SPMS phase?

A

axonal degeneration NOT inflammatory demyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

both white and gray matter

A

type 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

extensive gray matter

A

type 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

cortical lesions have intact blood brain barrier and almost no inflammation

A

gray matter

45
Q

microglia

A

gray matter

46
Q

cytotoxic t cell and macrophage

A

white matter

47
Q

axonal degeneration continue in environment other than the inflammatory demyelination lesion

A

chronic demyelination lesions

48
Q

Degeneration of chronically demyelinated axons is caused by imbalance between energy supply and demand

Limited energy supply due to ischemic

Chronically demyelinated axons increase the energy demand to restore nerve conduction, resulting in axoplasmic ATP production decreases and increases axoplasmic Ca2+

Loss of trophic support from oligodendrocytes

A

mechanisms underlying the degeneration of chronically demyelinated axons

49
Q

what are the major causes of primary demyelination in CNS

A
  1. Genetic mutation or abnormality
  2. Inflammatory damage to myelin and oligodendrocytes
  3. Oligodendroglial loss due to secondary damage from ischemia or infection
50
Q

ischemia or infection causes _____

A

Periventricular leukomalacia

51
Q

mutation of ____ causes of Pelizaeus–Merzbacher disease

52
Q
  1. Myelination
  2. Organizing the axonal cytoskeleton for maintenance of axonal integrity
  3. Trophic support for axons
  4. Participation in signaling networks with neurons
A

functions of oligodendrocytes

53
Q

In developmental myelination, _____ diameter axons are enwrapped with proportionally ____ myelin

A

larger; thicker

54
Q

in remyelination, the myelin sheath length and thickness remain roughly constant ______/_____regardless of the axon diameter

A

THINNER/SHORTER

55
Q

t/f G ratio is decreased in remyelination

A

f, it increases

56
Q

*Persistent activation of notch signaling during OPC differentiation
*Persistent activation of WNT signaling during OPC differentiation
*Failure of expression of YY1 transcription factor
*Impairment of HDAC recruitment during OPC differentiation
*No acute inflammation
*A sustained demyelinating insult
*Poor clearance of myelin debris
*Block axon derived signals during OPC differentiation

A

conditions that could cause remyelination failure

57
Q

axon degeneration that is morphologically similar to that occurring after injury

A

wallerian degeneration

58
Q

o _____ and ______ of the initial lesion is well defined
o Distal portions of injured axons fragment after _______ latent phase, lasting 36-44 hours in the mouse sciatic nerve

pathological features of wallerian degeneration

A

location; timing

predictable

59
Q

mutant protein will bring NMNAT1 and bring it to the cytoplasm

A

slow wallerian degeneration protein

60
Q

WLDS Delays Wallerian degeneration up to tenfold when ______ within axons

A

overexpressed

61
Q
  • Overexpression of WLDS (slow Wallerian degeneration protein)
  • Overexpression of NMNAT2
  • Disruption of palmitoylation of NMNAT2
  • Deletion of SARM1
  • Deletion of PHR1 (PAM‐Highwire‐Rpm‐1)
  • Decrease intra‐axonal calcium concentration
A

kinds of manipulations or conditions can delay Wallerian degeneration

62
Q

axon degeneration that is morphologically similar to that occurring after injury but may not be induced by traumatic injury

A

Wallerian-like degeneration

63
Q

Is axon degeneration in different neurodegenerative diseases all mediated by Wallerian-like mechanisms?

64
Q

cell body response to CNS and PNS injury

A

Chromatolysis

65
Q

the cut axonal end transforms into a ____ ____ -LIKE STRUCTURE

PNS response of axons to injury

A

growth cone

66
Q

what is the axon response to CNS injury

A

forms an end blub or retraction bulb

67
Q

what ish the PNS response to injury in non neuronal cells

A

clearance of axon and myelin debris by macrophages

68
Q

proliferation and hypertrophy of all 3 types of glial cells (astrocytes, microglia, and oligodendrocytes)

A

reactive gliosis (non neuronal cells response to CNS injury)

69
Q

upregulate expression of chondroitin sulfate proteoglycans and for glial scar

A

Reactive astrocytes
(non neuronal cells response to CNS injury)

70
Q

: 1st injury at the peripheral branch increases the regenerative responses to the second lesion

A

conditioning lesions

71
Q
  • Neuropoietic cytokines
  • Cyclic AMP (cAMP) increase
  • Increase axonal transport
  • Increase local protein synthesis
  • Silencing of electrical activity
A

five mediators that play a role in the effect of a conditioning lesion on axon regeneration

72
Q
  1. Provide trophic factors and cytokines or re‐activate trophic responses
  2. Downregulate suppressor of cytokine signaling 3 (SOCS3) by increasing cAMP levels to promote inflammatory cytokine‐ induced activation of axon regeneration
  3. Activate GSK3 to regulate microtubule dynamics for growth cone formation
  4. Eliminating PTEN to activate mTOR kinase to increase protein synthesis for axon regeneration
  • PTEN↓, SOCS3↓
  • cAMP↑, cytokine↑, mTOR↑, GSK3↑ neurotrophic factors ↑
A

functions to promote axon regeneration

73
Q

NMNAT2 is found in the ____ and ____- and is abundant in the brain

A

cytoplasm + axoplasm

74
Q

NMNAT1 is stably localized to the ____ and widely expressed

75
Q

WLDS is predominantly nuclear but small amounts of WLDS are also present in axons and this is the location (the _______) where WLDS acts to delay injury‐induced degeneration

76
Q

***which of the following events does not occur in the replacing remitting phase of MS

A

irreversible neurological disability and dysfunction

77
Q

***which of the following statements regarding MS is NOT correct

A

the irreversible neurological decline int he secondary progressive state of MS if mainly cause by inflammatory demyelination

78
Q

t/f RNA from both mutant alleles are transcribed and spliced normally but are retained in foci within the nucleus and ARE TRANSLATED INTO PROTEINS

A

F, it is not translated into proteins

79
Q

t/f FMR1 mRNA is not translated to protein and CGG repeat‐containing transcripts

80
Q

Binding of androgen to the polyglutamine‐expanded AR and the subsequent translocation of mutated AR to the nucleus are NOT required for onset of disease t/f

A

FALSE, IT IS REQUIRED

81
Q

both fragile X syndrome and fragile x-associated tremor ataxia syndrome (FXTAS) are caused by a repeat expansion in the same gene, the FMR1, but they show different clinical symptoms, why? ***ON EXAM

A

b/c FMRI transcripts are not translated in FXTAS, resulting in the RNA gain of function based pathogenic mechanism and DRAXA us caused by a different loss of protein function based mechanism

82
Q

why does spinobulbar muscular atrophy mainly affect males **ON EXAM

A

females do not have enough androgens to bring mutated androgen receptors to the nucleus to mediate their pathogenic functions

83
Q

Huntington’s disease is a _____ movement disorder

A

hyperkinetic

84
Q

In HD, medium spiny neurons that project to the ____ ____external degenerate

A

globus pallidus

85
Q

Huntingtin uses HEAT repeats to mediate protein‐protein interactions and is a
______ ____ protein **ON EXAM

A

multifunctional scaffold protein

86
Q

t/f normal and mutated huntingtin interact differently with numerous other proteins

87
Q

Amyotrophic lateral sclerosis is NOT a polyglutamine disease t/f

88
Q

*** ON EXAM
which disease affects what type of neuron in ALS, PLS, PMA, SMA

A

ALS– both upper and lower

PLS – upper motor neurons

PMA – lower motor neurons

SMA – lower motor neuron and is INHERITED

89
Q

ALS and FTLD are the same disease with same or different clinical spectrums

90
Q

which of the following neuronal types is involved in amyotrophic lateral sclerosis **ON EXAM

A

UMN, LMN, Frontal cortical neurons, temporal cortical neurons

91
Q

WHICH MOTOR NEURON IS MOST VULNERABLE

A

FF motor neuron

92
Q

WHICH MOTOR NEURON IS LESS VULNERABLE

A

FFR motor neuron

93
Q

____ ____ motor neurons are most resistant in ALS

A

slow tonic motor neurons are most resistant in ALS

94
Q

*** ON EXAM Which of the following statements referring ALS is not correct

A

glial cells are not involved in the pathogens of ALS

95
Q

*** ON EXAM which of the following statements regarding the pathogenic proteins in ALS is not correct

A

n ALS, only mutant superoxide dismutase 1 (SOD1) becomes misfiled and wild type SOD1 does not misfold

96
Q

t/f TDP43 always need to be mutated to cause ALS

97
Q

t/f Both TDP43 deficiency and TDP43 (wild‐type and mutant) overexpression are hazardous to the cell

98
Q

t/f MS is inherited

A

FALSE NOT INHERITED

99
Q

what is the following statements regarding MS is not correct ** ON EXAM

A

the irreversible neurological decline in the secondary progressive state of MS is mainly caused by inflammatory demyelination

100
Q

which of the following events does not occur in the relapsing remitting phase of MS ***ON EXAM

A

irreversible neurological disability and dysfunction

101
Q

***differentiation failure represents a major cause of remyelination failure (failure happens mostly in the_____ stage)

A

differentiation

102
Q

t/f remyelination depends as much on the precise timing of action as on the presence or absence of certain factors

103
Q

___ is the most important factor for remyelination failure

104
Q

***is there reactive gliosis in PNS and generates glial scar

105
Q

Expansion of the _____ repeat in 5’-UTR of FMR1 gene causes Fragile X Syndrome.

106
Q

-loss of FMRP protein,
-maximum translation of FMRP target mRNAs,
-exaggerated mGluR-dependent long-term depression (LTD),
–>resulting in abnormal synapse development and immature synapse

A

pathogenic processes of fragile X syndrome

107
Q

15% of MS patients, with rare or no relapses

A

Primary progressive MS (PPMS)

108
Q

_____ matter has immune mediated inflammation